Silvestro, Marcello
Tessitore, Alessandro
Caiazzo, Giuseppina
Scotto di Clemente, Fabrizio
Trojsi, Francesca
Cirillo, Mario
Esposito, Fabrizio
Tedeschi, Gioacchino
Russo, Antonio http://orcid.org/0000-0002-0601-0475
Article History
Received: 30 June 2021
Accepted: 10 August 2021
First Online: 28 August 2021
Declarations
:
: The study was approved by the Ethics Committee of University of Campania “Luigi Vanvitelli”, and written informed consent was obtained from all subjects according to the Declaration of Helsinki.
: All the co-authors have reviewed and approved the contents of the manuscript and agree to the conditions outlined in the Authorship section.
: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article:Dr. Silvestro has received speaker honoraria from Novartis, Teva and Lilly.Professor Tessitore has received speaker honoraria from Novartis, Schwarz Pharma/UCB, Lundbeck, Abbvie and Glaxo.Professor Tedeschi has received speaker honoraria from Sanofi-Aventis, Merck Serono, Bayer Schering Pharma, Novartis, Biogen-Dompé AG, Teva and Lilly; has received funding for travel from Bayer Schering Pharma, Biogen-Dompé AG, Merck Serono, Novartis and Sanofi Aventis; and serves as an associate editor of Neurological Sciences.Professor Russo has received speaker honoraria from Allergan, Lilly, Novartis and Teva and serves as an associate editor of Frontiers in Neurology (Headache Medicine and Facial Pain session).The other authors have nothing to declare.